
Nattokinase is popular online because one study suggested it may shrink artery plaque, while aspirin advice has flipped more than once. The two work in different ways, have very different kinds of evidence, and both carry bleeding risks. Here is what each does, what the studies found and why knowing what is in your arteries may change the answer. (Based on the insights of Dr. Ford Brewer)
Key Takeaways
- Nattokinase is an enzyme from fermented soybeans that may break down clot mesh and clot-forming material; aspirin permanently switches off platelet clumping.
- One six-month study found carotid plaque area fell by about a third with nattokinase, but a longer double-blind trial found no change; the second used a lower dose, and neither measured heart attacks.
- Aspirin has about 60 years of outcome data (about 20% fewer second heart attacks in men who had a prior one) but in healthy people the benefit is small and bleeding cancels most of it.
- A calcium-score study suggested aspirin helped people with meaningful artery calcium far more than it harmed, and the reverse for a score of zero.
- Both carry bleeding risks, nattokinase dosing is not standardized, and case reports of serious bleeds exist when combined with aspirin or other blood thinners.
Why This Comparison Matters
Nattokinase has become one of the most popular supplements online because some research suggests it may reduce artery plaque within months, which is appealing to people who would rather not add another prescription. Meanwhile, advice on aspirin has flipped more than once. It was handed out freely decades ago to people over 50 or 60. Then the US Preventive Services Task Force advised against starting it on the basis of age alone, and now some preventive cardiologists argue that aspirin may make sense again for people who have artery plaque and are at high risk. Getting this wrong in either direction has a cost: a heart attack that happened even though lab numbers looked fine, or a serious bleed from something assumed to be harmless because it came in a supplement bottle. The views below reflect one reading of the evidence, not settled consensus, so decisions belong with your own doctor.
What Nattokinase Does
Nattokinase is an enzyme extracted from natto, a dish of fermented soybeans eaten for centuries as a traditional breakfast in Japan. It is not a vitamin. It has effects similar to some blood-thinning medicines yet is sold as a supplement. It appears to act in three ways:
- Directly, by breaking apart the fibrin mesh that holds a clot together.
- Indirectly, by taking the brake off the body’s own clot-dissolving system.
- Upstream, by lowering the raw material in the blood that is used to build a clot.
Its effects on the blood can be measured a few hours after a single dose.
What Aspirin Does
Aspirin works on a different part of the clotting system. Platelets, small cell fragments, clump together to plug a leak, and one sends a signal to the others to join in. Aspirin switches off that signal permanently for each platelet it touches, and since platelets last about a week to ten days, new ones must replace them. That is why the dose is low: wiping out all platelet function at once would be dangerous. Strictly speaking, aspirin does not thin the blood; it turns down how eager platelets are to clump. In short, nattokinase works on a clot that is already forming, while aspirin works on the platelets that start the clot, so the two are not interchangeable.
What The Evidence Shows For Nattokinase
One six-month study in people with plaque in the carotid arteries of the neck found that plaque area fell by roughly a third, the artery wall became measurably thinner, and the result beat the statin it was compared with. That is a striking result, and it spread widely online.
A second, longer double-blind placebo-controlled trial of a couple of hundred people scanned the neck arteries every six months and found no change in artery wall thickness, stiffness or blood pressure. The fair objection is that the trial that found nothing used a lower dose than the trial that found something, so dose may matter, but this is unknown. Both studies measured pictures of the artery, not whether people had fewer heart attacks, and that is an important limitation.
What The Evidence Shows For Aspirin
No study has asked whether aspirin shrinks plaque, so it has nothing to show on that scoreboard. What it has is about 60 years of data on heart attacks and strokes. In men who had already had a heart attack, aspirin cut the odds of a second one by about 20%, and those studies were large, long and repeated in different countries.
In people with no known heart disease, the picture is different. Three large trials in healthy people found the protection was real but small, and small enough that the bleeding aspirin caused cancelled out most of what it prevented. That is why the Task Force stopped recommending it based on age alone.
Why What’s In Your Arteries May Change The Answer
Those trials sorted people using risk calculators, not by what was in their arteries. One study did the reverse, sorting men by a coronary artery calcium score, a scan that counts calcium in the heart’s arteries. In men with a meaningful amount of calcium, the heart attacks prevented by aspirin outweighed the bleeds caused by a wide margin. In men with a calcium score of zero, it ran the other way, with more bleeds than heart attacks prevented. For those people, the argument goes, the scan takes aspirin off the table.
A calcium score counts only the older, scarred-over, more stable kind of plaque, though it can signal that softer plaque is also present. The soft, non-calcified plaque is the dangerous kind that can rupture and throw a clot. A carotid intima-media thickness (CIMT) scan, which starts as an ultrasound and measures the thickness of the artery wall, can pick up soft plaque that a calcium score misses. A stress test usually becomes positive only when blood flow is reduced by more than about 50%, and it has been said that about two-thirds of heart attacks occur in people with blockages under 50%, so passing a stress test does not rule out plaque.
In animals, low-dose aspirin changed plaque shape: fewer fat-laden immune cells and a thicker, tougher cap. In people, inflammation markers come down. This suggests aspirin may help stabilize plaque, which is different from clearing it out.
Bleeding Risk: Both Carry It
It is tempting to assume a supplement cannot hurt, but both carry a real bleeding risk. Aspirin’s bleeding risk has been counted, its dose is fixed and its manufacturing is regulated. Nattokinase has none of that: the effect on clotting is not precisely known, doses may vary by lot and manufacturer, and interactions are not well understood. Case reports describe bleeding in the brain in a man taking nattokinase with aspirin, abdominal bleeding in an elderly woman taking it with aspirin, bleeding in the eye, and bleeds with newer blood thinners such as rivaroxaban (Xarelto) and apixaban (Eliquis). Case reports cannot give actual rates, but they are a warning. No trial shows that combining nattokinase and aspirin adds benefit worth that risk.
Do not combine aspirin and nattokinase, or take nattokinase with prescription blood thinners or clopidogrel, unless you have had a very clear discussion with your doctor about the risks. People with atrial fibrillation face a much higher stroke risk, and aspirin does not prevent that kind of stroke, so they need a different type of blood thinner decided by their doctor.
One Reading Of The Evidence
If a scan shows plaque and nothing disqualifies you (no active ulcer, serious bleeding risk, uncontrolled blood pressure, allergy, prescription blood thinner or upcoming surgery), some preventive cardiologists would favor low-dose aspirin under a doctor’s watch, because that is where the evidence for preventing events is strongest and manufacturing is tightest. For people who cannot tolerate aspirin and do have plaque, nattokinase may be a reasonable second choice. This is an opinion and not settled consensus. Many people reasonably choose differently, and what matters most is understanding what is and is not known, and making the decision with a doctor who supports you.
What Matters Even More
Neither choice built the plaque in the first place. Refined carbohydrates and insulin resistance are major drivers, and a blood thinner may support the work of fixing the problem but does not replace it. Practical steps include:
- Test, do not guess: ask about imaging of your arteries and about tests such as an oral glucose tolerance test with insulin response, and about cholesterol particle (fractionation) testing, since a yearly basic cholesterol panel may miss hidden disease.
- Cut high-glycemic carbohydrates, and act as though you might have prediabetes.
- Exercise with intensity as your doctor allows.
- Fix roadblocks such as sleep problems and stress.
Frequently Asked Questions
Can nattokinase reverse plaque?
One six-month study in people with carotid plaque found plaque area fell by roughly a third and beat a statin comparison, but a longer double-blind trial found no change in artery wall thickness or stiffness. The second used a lower dose, so dose may matter. Neither study measured heart attacks.
Should I take aspirin to prevent a heart attack?
It depends on your situation, and the decision belongs with your doctor. In people with no heart disease, the benefit is small and bleeding cancels most of it, which is why guidelines no longer recommend starting it on age alone. In people who have already had a heart attack, it lowered the odds of another by about 20%.
Is nattokinase safer than aspirin because it is natural?
Not necessarily. Both carry bleeding risks. Aspirin’s risk has been counted, the dose is fixed and manufacturing is regulated, while nattokinase dosing can vary by lot or manufacturer and its effects on clotting are not precisely known. Case reports describe serious bleeds when it was combined with aspirin or other blood thinners.
What does a calcium score have to do with aspirin?
One study that sorted men by coronary artery calcium score found that in those with meaningful calcium, aspirin prevented more heart attacks than the bleeds it caused, while in those with a score of zero it caused more bleeds than it prevented. Some doctors therefore use scans to decide, though this is not settled consensus.
Questions To Ask Your Doctor
- ☐ Ask whether imaging (calcium score or CIMT) makes sense for you
- ☐ Ask about tests for insulin resistance and cholesterol particles
- ☐ Ask whether aspirin is right given your bleeding risk
- ☐ Never combine aspirin, nattokinase and prescription blood thinners without medical advice
- ☐ Tell your doctor about every supplement you take
- ☐ Seek urgent care for signs of serious bleeding
This article is for general educational purposes and is not medical advice. It reflects one reading of the evidence, not consensus. Do not start, stop or swap aspirin, nattokinase or any blood thinner without talking to your doctor, and never combine them with prescription blood thinners such as rivaroxaban, apixaban or clopidogrel without medical guidance. Seek urgent care for signs of serious bleeding.

